GILEAD SCIENCES SL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00002398
- Locations
- 🇺🇸
Gilead Sciences Inc, Foster City, California, United States
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 15
- Registration Number
- NCT00002128
- Locations
- 🇺🇸
Johns Hopkins Univ, Baltimore, Maryland, United States
A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 300
- Registration Number
- NCT00002453
- Locations
- 🇺🇸
Tenofovir Coordinating Center, Foster City, California, United States
Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
Not Applicable
Completed
- Conditions
- HIV InfectionsHerpes Simplex
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00002181
- Locations
- 🇺🇸
Mem Med Group Inc, Long Beach, California, United States
🇺🇸AIDS Healthcare Foundation Labs, Los Angeles, California, United States
🇺🇸Sharp Mission Park / Med Group, Oceanside, California, United States
A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 45
- Registration Number
- NCT00002206
- Locations
- 🇺🇸
Anderson Clinical Research, Philadelphia, Pennsylvania, United States
🇺🇸Johns Hopkins Univ Clinical Pharmacology, Baltimore, Maryland, United States
🇺🇸Anderson Clinical Research / Inc, Pittsburgh, Pennsylvania, United States